Anne Eldrup

Anne Eldrup currently serves as Chief Operating Officer at Plythera Inc and Chief Development Officer at MoglingBio Inc, both positions held since 2023. Prior roles include Chief Operating Officer at Thyron Pharmaceuticals Inc and Executive Director for strategy and collaboration at Gilead Sciences, where leadership in collaboration management and research strategy was demonstrated. A significant tenure at Boehringer Ingelheim included roles as Executive Director in Alliance Management and as International Project Leader for a specialty care product, alongside various leadership positions in R&D project management. Anne Eldrup holds a PhD in Organic Synthesis and Biomolecular Recognition from Københavns Universitet - University of Copenhagen.